JP2014532764A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532764A5
JP2014532764A5 JP2014541155A JP2014541155A JP2014532764A5 JP 2014532764 A5 JP2014532764 A5 JP 2014532764A5 JP 2014541155 A JP2014541155 A JP 2014541155A JP 2014541155 A JP2014541155 A JP 2014541155A JP 2014532764 A5 JP2014532764 A5 JP 2014532764A5
Authority
JP
Japan
Prior art keywords
nitric oxide
red blood
blood cell
cell sample
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014541155A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532764A (ja
JP6389125B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/063690 external-priority patent/WO2013070592A1/en
Publication of JP2014532764A publication Critical patent/JP2014532764A/ja
Publication of JP2014532764A5 publication Critical patent/JP2014532764A5/ja
Application granted granted Critical
Publication of JP6389125B2 publication Critical patent/JP6389125B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014541155A 2011-11-07 2012-11-06 赤血球の処理法 Active JP6389125B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161556661P 2011-11-07 2011-11-07
US61/556,661 2011-11-07
PCT/US2012/063690 WO2013070592A1 (en) 2011-11-07 2012-11-06 Treatment of red blood cells

Publications (3)

Publication Number Publication Date
JP2014532764A JP2014532764A (ja) 2014-12-08
JP2014532764A5 true JP2014532764A5 (enExample) 2015-12-24
JP6389125B2 JP6389125B2 (ja) 2018-09-12

Family

ID=48290479

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014541155A Active JP6389125B2 (ja) 2011-11-07 2012-11-06 赤血球の処理法

Country Status (6)

Country Link
US (1) US9572833B2 (enExample)
EP (1) EP2776047A4 (enExample)
JP (1) JP6389125B2 (enExample)
CN (1) CN104159591A (enExample)
HK (1) HK1200355A1 (enExample)
WO (1) WO2013070592A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12529737B2 (en) * 2019-03-25 2026-01-20 Ronald Day Systems and methods for using improved contrast agent in performing and MRI
WO2021015235A1 (ja) * 2019-07-22 2021-01-28 学校法人北里研究所 透析装置
CN111919835B (zh) * 2020-08-06 2022-02-08 温州医科大学 维持红细胞活性的保存液
EP4123303A1 (en) * 2021-07-20 2023-01-25 German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH Non-invasive method for predicting the hemoglobin and iron content in prbc units
EP4633693A1 (en) 2022-12-16 2025-10-22 Fresenius Medical Care Holdings, Inc. Systems and methods for using nitric oxide in dialysis
WO2025212681A1 (en) * 2024-04-01 2025-10-09 Ohio State Innovation Foundation Compositions, kits, and methods for the preservation of blood products

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
DE69127756T2 (de) 1990-12-05 1998-02-05 The General Hospital Corp., Charlestown, Mass. Verwendung von no zur behandlung oder prävention der bronchokonstriktion
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5536241A (en) 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5296466A (en) 1992-02-19 1994-03-22 Board Of Regents, The University Of Texas System Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
US5423738A (en) * 1992-03-13 1995-06-13 Robinson; Thomas C. Blood pumping and processing system
DE59409834D1 (de) 1993-04-17 2001-09-27 Messer Griesheim Austria Ges M Gerät zur kontrollierten Zudosierung von NO zur Atemluft von Patienten
TW381022B (en) 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
GB9320978D0 (en) 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
SE9303486L (sv) 1993-10-22 1995-04-23 Siemens Elema Ab Metod vid bestämning av den funktionella residualkapaciteten för lungor samt en ventilatoranordning för bestämning av den funktionella residualkapaciteten
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
SE503876C2 (sv) 1994-11-30 1996-09-23 Kjell Alving Detektion av inflammatoriska tillstånd i tarmkanalen genom att mäta kväveoxidhalten i ett prov taget ur tarmlumen
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
US6627738B2 (en) * 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
JP2000510448A (ja) * 1996-04-05 2000-08-15 ザ ジェネラル ホスピタル コーポレーション 異常ヘモグロビン症の治療
WO1998008500A1 (en) 1996-08-26 1998-03-05 Board Of Regents, The University Of Texas System Hypertonic arginine compositions and methods
CA2278784A1 (en) * 1997-02-06 1998-08-13 Jonathan S. Stamler No-modified hemoglobins and uses therefor
WO1998050430A2 (en) * 1997-05-02 1998-11-12 Somatogen, Inc. Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
US5900402A (en) 1997-05-29 1999-05-04 Enzon, Inc. Method of reducing side effects associated with administration of oxygen-carrying proteins
US6087087A (en) * 1997-07-03 2000-07-11 Takashi Yonetani Treatment of hemoglobin with nitric oxide
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
US6089229A (en) 1998-05-26 2000-07-18 Datex-Ohmeda, Inc. High concentration no pulse delivery device
US6139506A (en) 1999-01-29 2000-10-31 Instrumentarium Oy Method for measuring pulmonary functional residual capacity
IL147112A0 (en) * 1999-06-14 2002-08-14 Ford Henry Health System Nitric oxide donors for inducing neurogenesis
EP1204870B1 (en) * 1999-08-02 2010-01-20 Duke University Method for determining physiological effects of hemoglobin
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
US7516742B2 (en) 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
US6811778B2 (en) 2001-09-10 2004-11-02 Biopure Corporation Method for improving oxygen transport by stored red blood cells
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
AU2003210952A1 (en) * 2002-02-08 2003-09-02 Gambro, Inc. Nitric oxide in a pathogen inactivation process
EP1514103A4 (en) * 2002-05-29 2006-05-24 Univ Duke MEASUREMENT OF NITROGEN MONOXIDE IN HEMOTOXIC GASES, AND TREATMENT BASED ON THIS MEASURE
WO2005004884A2 (en) 2003-07-09 2005-01-20 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
WO2005025511A2 (en) 2003-09-10 2005-03-24 Cedars-Sinai Medical Center Potassium channel mediated delivery of agents through the blood-brain barrier
US7485324B2 (en) * 2003-09-29 2009-02-03 Pulmonox Technologies Corporation Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
WO2005077005A2 (en) 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
US20050234030A1 (en) 2004-04-20 2005-10-20 Wilmin Bartolini Modulators of CRTH2, COX-2 and FAAH
US7362274B1 (en) 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
EP1799210A1 (en) 2004-10-05 2007-06-27 Bayer HealthCare AG A guanylate cyclase stimulator and nitric oxide for treating bronchoconstriction and pulmonary vasconstriction
US7530353B2 (en) 2005-09-21 2009-05-12 The General Electric Company Apparatus and method for determining and displaying functional residual capacity data and related parameters of ventilated patients
WO2007076318A2 (en) 2005-12-21 2007-07-05 Smithkline Beecham Corporation Camphor-derived cxcr3 antagonists
KR20090087900A (ko) * 2006-11-07 2009-08-18 더 제너럴 하스피탈 코포레이션 혈관작용성 산소운반체에 의해 유도되는 혈관수축의 감소
WO2009038796A1 (en) * 2007-09-20 2009-03-26 Wake Forest University Health Sciences Methods of treatment for hemolysis
DK3266463T3 (da) * 2009-06-09 2024-01-08 Prolong Pharmaceuticals Llc Hæmoglobinsammensætninger

Similar Documents

Publication Publication Date Title
KR102701687B1 (ko) 혐기성 혈액 저장 및 병원체 불활성화 방법
Sharif et al. Immune disorders in hemodialysis patients
Ho et al. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model
TR201906285T4 (tr) İntraoperatif otolog kan kurtarımından tümör hücrelerinin giderilmesi.
JP2015515462A5 (enExample)
CN108289987A (zh) 用于体外循环二氧化碳去除的方法
CN107735095A (zh) 储存全血的方法及其组合物
FR2996413A1 (fr) Procede pour conserver le sang placentaire
AU2016366698A1 (en) Method and apparatus for scavenging plasma free hemoglobin
CN102466730A (zh) 一种新的配制血型反定型试剂的方法
UA113290C2 (xx) Застосування гемоглобіну або міоглобіну, завантаженого на його ділянку зв'язування кисню монооксидом вуглецю, для зовнішньої обробки ран
CN112218940A (zh) 组合物、细胞保存组合物、细胞培养组合物、细胞制剂、包含微小气泡的对象物的制造方法、细胞的保存方法、细胞的培养方法和细胞制剂的制造方法
US9572833B2 (en) Treatment of red blood cells
JP2025106261A (ja) 外傷の方法および治療
US20230173155A1 (en) Dialysis system for treating sepsis
IN2014MN02137A (enExample)
Uvizl et al. Biochemical changes in the patient’s plasma after red blood cell transfusion
Kim et al. Therapeutic plasma exchange using the Spectra Optia cell separator compared with the COBE Spectra
CN103989703B (zh) 一种提高氢气在水中溶解度的方法及其应用
JPH06511013A (ja) 血液、組織および生物流体のアルブミンーヨウ素保存
CN101744798A (zh) 一种含钙枸橼酸盐浓缩抗凝血液透析液
CN107649102B (zh) 一种复合型中空纤维吸附树脂的制备方法
CN103387613B (zh) 一种血红蛋白及血红蛋白氧载体病毒灭活的方法
Lockhart et al. 367 Red Blood Cell Exchange for Treatment of Acquired Methemoglobinemia in a Hospitalized Patient: A Case Report
Ryabinin et al. A device for albumin and cytosol detoxication